August 30, 2016 1:38 PM ET

Biotechnology

Company Overview of neXus therapeutics, Inc.

Company Overview

neXus therapeutics, Inc. operates as a biopharmaceutical management company. It engages in the management of Transport Pharmaceuticals, Inc. and the development of portable, handheld device to deliver antiviral medications topically for the treatment of herpes labialis. The company also manages the design and development of devices based on transport technology to treat other dermal indications. neXus therapeutics is based in Framingham, Massachusetts.

40 Speen Street

Suite 402

Framingham, MA 01701

United States

Phone:

508-872-0433

Fax:

508-872-0922

Key Executives for neXus therapeutics, Inc.

Founder, Chief Executive Officer and President
Vice President of Research and Development
Director of Quality Assurance
Director of Regulatory Affairs
Associate Director of Clinical Operations
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact neXus therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.